07:25:33Philippines

Accustem Sciences Inc. (ACUT)

OTC Markets

Key stats Fiscal year 2025

Income statement

Net income
-1,756,096
Operating income
-1,756,096
Earnings per share
-0.12
R&D expense
281,014

Growth and profitability

Return on assets
-113.34

Balance sheet

Total assets
1,549,446
Total liabilities
4,951,071
Shareholders' equity
-3,401,625
Current ratio
0.01

Cash flow and ratios

Operating cash flow
-850,389

Shareholder returns

Shares outstanding
16,072,267
Revenue and net income
Earnings per share

Company information

Headquarters
New York, NY
Exchange
OTC Markets
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Accustem Sciences Inc. trades on OTC Markets under the ticker symbol ACUT. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis